6.08 USD
↗ 0.24 (4.11%)AT CLOSE (11:59 AM EDT)
AN2 Therapeutics, Inc. Common Stock
ANTXNASDAQ • USD
5.97
↘ 0.11 (1.81%)
POST MARKET (AS OF 07:34 PM EDT)
Post Market
AS OF 07:34 PM EDT
5.97
↘ 0.11 (1.81%)
Market: CLOSED
Shares of AN2 Therapeutics, Inc. Common Stock (ANTX) are trading at $6.10. Technicals currently rate "Strong Buy" while our fundamental analysis reads "Neutral". Key drivers include a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bullish Golden Cross on the moving averages and bullish moving average alignment. On the valuation side, ANTX appears attractively valued relative to sector peers across key multiples.
Technical & fundamental data as of Aug 6, 2026.
Open?$5.82
High?$6.26
Low?$5.81
Prev. Close?$5.84
Volume?207.3K
Avg. Volume?330.1K
VWAP?$6.07
Rel. Volume?0.63x
Bid / Ask
Bid?$3.08 × 400
Ask?$6.39 × 300
Spread?$3.31
Midpoint?$4.73
Valuation & Ratios
Market Cap?210.3M
Shares Out?36.0M
Float?25.1M
Float %?69.7%
P/E Ratio?N/A
P/B Ratio?2.57
EPS?-$0.96
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
AN2 Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform. The company has a pipeline of boron-based compounds in development for Chagas disease, non-tuberculous mycobacterial (NTM) and melioidosis, along with early-stage programs focused on targets in infectious diseases and oncology. Product candidate AN2-502998 Epetraborole.
Themes
Employees
21
Market Cap
210.3M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2022-03-25
Address
1300 EL CAMINO REAL, SUITE 100
MENLO PARK, CA 94025
Phone: (650) 331-9090
MENLO PARK, CA 94025
Phone: (650) 331-9090
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+2/3)
Medium-Term (Wave)?▲ Bullish(+3/3)
Short-Term (Ripple)?▲ Bullish(+2/3)
MA Alignment?Golden Alignment
Full Technical Analysis →Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?100
Momentum?50
Short Sent.?24
Piotroski F-Score?0/9Weak
Altman Z-Score?17.72Safe
Confidence?40%Low
Short InterestHigh
Short % of Float?9.71%Elevated
Short Interest?2.4M
Days to Cover?9.9
Free Float25.1M
Avg Daily Volume246.0K
Settlement Date2026-07-15
Financial Health
Current Ratio?15.73Strong
Quick Ratio?15.73Strong
Cash Ratio?9.62Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score100/100
P/E?N/A▾
P/B?2.57CHEAP▾
Peers100
S&P63
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-4.2CHEAP▾
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?-42.3%WEAK▾
S&P3
ROA?-39.5%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?N/A
Enterprise Value?$156.8M
Fundamentals ratios updated end of day